Publication | Open Access

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Sls IiMycophenolate MofetilInflammatory Lung DiseaseAdvanced Lung DiseaseSystemic SclerodermaClinical TrialsPathologyPulmonary FibrosisSclerodermaMedicinePulmonary DiseaseParallel Group Trial